Aerovate Therapeutics Stock Quote AVTE - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

17.09

Bid

6.85

Ask

27.31

Volume

215,013

16.61 Day's Range 18.095

9.41 52 Week Range 32.415

Market Cap

472.308M

Previous Close

17.13

Open

17.35

Last Trade

17.94

Last Trade Time

Financial Volume

$ 3,726,283

VWAP

17.3305

Average Volume (3m)

173,206

Shares Outstanding

27,668,887

Dividend Yield

PE Ratio

-6.25

Earnings Per Share (EPS)

-2.73

Revenue

Net Profit

-75.52M

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aerovatetx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $17.13. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 9.41 to $ 32.415.

Aerovate Therapeutics currently has 27,668,887 shares outstanding. The market capitalization of Aerovate Therapeutics is $472.31 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -6.25.

Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference

Baseline characteristics reflect a PAH population with significant disease Topline data from Phase 2b portion of IMPAHCT study to be released in June 2024 Enrollment into the Phase 3 portion of...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights

Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Enrollment continues into the...

Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference

WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-4.77	-21.8206770357	21.86	21.9	16.61	234605	18.76983271	CS
4	-4.48	-20.7695873899	21.57	22.48	16.61	171004	19.96329296	CS
12	-6.02	-26.0493292947	23.11	32.415	16.61	173206	23.93267543	CS
26	1.69	10.974025974	15.4	32.415	14.56	131412	22.10040292	CS
52	-0.29	-1.66858457998	17.38	32.415	9.41	105525	19.3019527	CS
156	-10.91	-38.9642857143	28	32.415	7.74	101033	18.62725018	CS
260	-10.91	-38.9642857143	28	32.415	7.74	101033	18.62725018	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LUCYInnovative Eyewear Inc	$ 0.983 (428.49%)	944.4M
AKANAkanda Corporation	$ 4.07 (70.29%)	39.11M
TKLFYoshitsu Company Ltd	$ 0.3496 (53.33%)	84.5M
ONMDOneMedNet Corporation	$ 2.251 (53.13%)	136.04M
MRUSMerus NV	$ 59.92 (35.97%)	6.91M
VSTMVerastem Inc	$ 4.0901 (-66.42%)	19.68M
TOIIWOncology Institute Inc	$ 0.0443 (-55.61%)	280.55k
SNSESensei Biotherapeutics Inc	$ 0.7912 (-45.43%)	1.41M
GNLXGenelux Corporation	$ 2.61 (-43.26%)	3.32M
AUVIApplied UV Inc	$ 0.32 (-33.33%)	5.18M
LUCYInnovative Eyewear Inc	$ 0.983 (428.49%)	944.4M
GWAVGreenwave Technology Solutions Inc	$ 0.0843 (-4.85%)	428.98M
NCPLNetcapital Inc	$ 0.20 (14.42%)	191.35M
HLTHCue Health Inc	$ 0.0931 (-1.27%)	160.21M
ONMDOneMedNet Corporation	$ 2.251 (53.13%)	136.04M